CD44 and breast carcinoma: The Delta16HER2/SIRT6-OE tumors exhibit a more pronounced expression of CD44 and OCT3/4, two specific markers for breast cancer stem cells (BCSCs)82–84, a higher mammosphere-forming ability than controls in anchorage-independent conditions, and stem cell-like transcriptional signatures.